In addition to neurodevelopmental features, which seem to regress in adolescent patients with KLEFS1, as mentioned above, additional health issues, such as epilepsy with a prevalence of about 15%, are mentioned in large cohorts of KLEFS1 patients [4]. This evidence concerns the gene EHMT1 and epilepsy.